Andrew Bellinger
2020
In 2020, Andrew Bellinger earned a total compensation of $1M as Chief Scientific Officer at Verve Therapeutics.
Compensation breakdown
| Bonus | $126,000 |
|---|---|
| Option Awards | $540,000 |
| Salary | $350,000 |
| Other | $11,592 |
| Total | $1,027,592 |
Bellinger received $540K in option awards, accounting for 53% of the total pay in 2020.
Bellinger also received $126K in bonus, $350K in salary and $11.6K in other compensation.
Rankings
In 2020, Andrew Bellinger's compensation ranked 8,521st out of 13,090 executives tracked by ExecPay. In other words, Bellinger earned more than 34.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,521 out of 13,090 | 35th |
Division Manufacturing | 3,624 out of 5,621 | 36th |
Major group Chemicals And Allied Products | 1,465 out of 2,254 | 35th |
Industry group Drugs | 1,276 out of 1,954 | 35th |
Industry Pharmaceutical Preparations | 942 out of 1,459 | 35th |
Source: SEC filing on April 29, 2022.
Bellinger's colleagues
We found one more compensation record of an executive who worked with Andrew Bellinger at Verve Therapeutics in 2020.
2020
Sekar Kathiresan
Verve Therapeutics